We present a novel architecture for analyzing molecular communications systems in blood vessels for drug delivery and monitoring. This architecture leverages a big data platform for simultaneously using data produced by the existing simulation platforms, health records, and medical data acquisition systems. An included machine learning engine may provide useful insight for medical purposes.
INTRODUCTION
The field of molecular communications (MolCom) has attracted many researchers in the recent years. It combines Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than ACM must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from permissions@acm.org. the expertise of different areas, such as biology, ICT, nanotechnologies and others, with applications to different areas, such as the biomedical one [7] .
Significant steps have been done so far towards the definition of models and simulators that allow analyzing and predicting the behavior of such complex systems, such as the MolCom Markup Language [1] . However, the complexity of the considered biological environments typically allows analyzing only short-range communications systems, due to both the (slow) particle diffusive behavior and the (huge) number of interacting entities, and making the simulations of large areas for a long time challenging.
The main issues to take into account in the simulation of biological environments are related to (1) the huge amount of data produced, (2) support for batch and near real-time parallel processing, (3) scalability of both storage and processing, and (4) usage of machine learning (ML) libraries for specialized simulations.
In this paper, We propose a three layers architecture, depicted in Fig. 1 . The set of simulations results, which could also be generated by different simulators, are part of the layer 1 of the architecture. Layer 2 contains the results relevant to the desired analysis, which are also regarded as monitor points. Simulation results are jointly used with other informations, such as the electronic health records (EHRs) of a patient, by a processing engine staying at the layer 3. This engine can use ML algorithms, having the aim of delivering the desired insights.
SYSTEM ARCHITECTURE

Layer I: MolCom Data
Its functions and entities consist of the available data and the relevant generation process. Data can either be collected by medical sensors, or be extracted from EHRs, or be simulation results already performed, or generated by simulations still to be executed according to the needs of the entities staying at layer 2. Simulation results could be also generated by different molecular simulators. A noticeable example could be a case study composed of monitoring points along blood vessels for drug delivery [3] [4] [5] .
Layer II: System Model
This layer is composed by (a) blood vessel imaging, (b) placement of sensors, and (c) MolComML support.
Considering the above case study, the estimation of the biological parameters in blood vessels can be performed in any point of interest, starting from results available in other monitoring point. The main idea is that it is not necessary a continuous and fine grained simulation of the blood vessels when the parameters of interest do not change significantly along a portion of it. This means that it is sufficient to monitor a vessel in discrete time and space points in order to detect significant variations of the observed parameters.
The output formats for each monitoring point are defined in the MolComML [1] , which allows specifying the most suitable data format for analyzed scenario.
Layer III: the processing engine
A variety of ML or DL techniques could be used for blood vessel image segmentation. The detection of specific cell lines and delivered drug [3] [4] [5] [6] will generate a large amount of longitudinal and spatial data, reflecting the positions of the various monitoring points. The ensemble of sensors form a network.
Simulations performed using agent-based software, such as repast or using random forest approaches, could provide effective solutions to select optimal monitoring points locations. Both random forest or simulated annealing approaches could be also used to generate in silico vasculatures which closely match the data obtained from Magnetic resonance angiography (MRA), or fMRI, or known anatomical data for the vessels on all length scales [8] .
Once the geometry of the region of interest is available, we suggest to deploy a number of sensors in the order of the Strahler's number, which measure the branching complexity determined from the MRA image information. This optimization algorithm should take into account blood pressure averages and variances in different populations; it could be important to use database of blood pressure monitoring [2, 9, 10] . The positioning of the monitoring points could benefit also from the assumption that sensor locations are robust to small variations of vessels tree geometry. This assumption is based on the observation of quasi-modular tree-like structures of vessel arrangements. Consequently, the geometry of the deployment of sensor nodes could belong to a small number of classes of geometry. The different patterns could be learned using deep learning architectures such as convolution networks (supervised) and autoencoders (unsupervised).
Finally, ML techiques are used not only to select optimal sensor locations, but also to predict system behaviour by 
